Beam Therapeutics

Beam Therapeutics

Beam Therapeutics

Raised
$222M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$87,000,000
Venture capital (Series A) - 2018
ARCH Venture Partners F-Prime Capital Partners
Team Size
1–10
Employees
MedCity News

Gene editing company Beam Therapeutics aims for $100M IPO

Xconomy

Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs

$135,000,000 Venture capital (Series B)
FinSMEs

Beam Therapeutics Secures $135M in Series B Financing

Xconomy

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M

Science
$87,000,000 Venture capital (Series A)
FinSMEs , PE HUB , MedCity News

Beam Therapeutics Raises up to $87M in Series A Financing

Science Education